Colonoscopic polypectomy

Colorectal cancer (CRC) is one of the most common causes of cancer-associated morbidity and mortality among men and women. Factors that increase and decrease risk are well established and should be applied in clinical practice. Several screening methods are highly effective for lowering incidence and mortality of CRC in average risk individuals over age 50, and therefore CRC screening has been strongly endorsed by medical societies. Recognizing high risk syndromes is important for identifying individuals who would benefit from earlier and more comprehensive cancer screening. Genetic mutations underlying some high risk syndromes permits gene testing of family members in order to lower their risk of CRC. Early stage CRC is highly curable with surgery alone. For patients with more advanced stage tumors, effective chemotherapy and radiation therapy improves outcome.